Overview
Claes Moller practices in Oerebro, Sweden. Moller is rated as an Experienced expert by MediFind in the treatment of Riboflavin Transporter Deficiency Neuronopathy. Their top areas of expertise are Usher Syndrome, Hearing Loss, Retinitis Pigmentosa, and Retinopathy Pigmentary Mental Retardation.
Their clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Riboflavin Transporter Deficiency Neuronopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Usher SyndromeMoller isDistinguished. Learn about Usher Syndrome.
- Advanced
- Alstrom SyndromeMoller isAdvanced. Learn about Alstrom Syndrome.
- Hearing LossMoller isAdvanced. Learn about Hearing Loss.
- Retinitis PigmentosaMoller isAdvanced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- Experienced
- AmenorrheaMoller isExperienced. Learn about Amenorrhea.
- CAPOS SyndromeMoller isExperienced. Learn about CAPOS Syndrome.
- Congenital CytomegalovirusMoller isExperienced. Learn about Congenital Cytomegalovirus.
- Familial OtosclerosisMoller isExperienced. Learn about Familial Otosclerosis.
- Infant Hearing LossMoller isExperienced. Learn about Infant Hearing Loss.
- Late-Onset Retinal DegenerationMoller isExperienced. Learn about Late-Onset Retinal Degeneration.